Signify Health, a value-based care-focused analytics platform, will be ceasing its Episodes of Care Services (ECS) business and exiting the Centers for Medicare and Medicaid Services’ Bundled Payments for Care Improvement-Advanced (BPCI-A) model, the c…
The federal government recovered more than $5 billion in healthcare fraud settlements and judgments in fiscal year 2021, according to the joint annual government Health Care Fraud and Abuse Control Program Annual Report from the of the Departments of J…
In a bid to make diabetes treatment more affordable, California Governor Gavin Newsom said in a recent Twitter video that the state will begin making its own low-cost insulin, using a $100 million budget to kick-start development and manufacturing of …
Employers of all sizes are looking to bolster their health benefit options in 2023 with an eye toward improving recruitment and retention, and will focus on affordability and access, according to a new Mercer survey.
One in five adults in the U.S. have received an unexpected medical bill this year, even after a federal ban on surprise medical billing, according to a new survey from Morning Consult.
The Centers for Medicare and Medicaid Services has issued the 2023 Physician Fee Schedule (PFS) proposed rule, which seeks to expand access to behavioral health services, Accountable Care Organizations, cancer screening and dental care, with a focus on…
The Department of Health and Human Services, through the Centers for Medicare and Medicaid Services, has released a suite of resources meant to improve CMS and state oversight of Medicaid and Children’s Health Insurance Program managed care programs – …
The U.S. Food and Drug Administration on Wednesday revised the Emergency Use Authorization for Pfizer’s antiviral COVID-19 treatment Paxlovid, allowing pharmacists to prescribe the treatment, with limitations.
Paxlovid is authorized for the treatment o…
Senate Democrats have carved out a deal on legislation that would attempt to lower prescription drug costs for Americans by allowing Medicare to negotiate for lower drug prices.
COVID-19 was the leading cause of death for people between the ages of 45 and 54 in 2021, accounting for 16.8% of all deaths in that age group, found a study in JAMA Internal Medicine. It was the third leading cause of death during the height of the pa…
